{"name":"Newave Pharmaceutical Inc","slug":"newave-pharmaceutical-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNRkVwOTJpRW84UDFuWmVNR25JLXJmS2d1cE1TQ3VzQUtiSTJROFFXTVFhZFBkTlprdm8yQTk2djFDclFlVTRtNUhGYWJqOFkzQVhIdVlELU9jaUZzNXRKTDNtbmN2VUExaE9LTEpSTDRqcWp0MFFMTHZXYmozOEZESUxBbjFUa3F5?oc=5","date":"2026-03-25","type":"pipeline","source":"The Business Journals","summary":"Takeda launches restructuring plan targeting $1.25B in savings - The Business Journals","headline":"Takeda launches restructuring plan targeting $1.25B in savings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOOGEyanVQZ0VYM3dTY1JxWjJLWHhqSkU1Z01odXRaWS04ZllsaGlYYldZbzVDRDhIT1cwXzFVUS02TjlPREp5c3YweWMwb29ic2lpM2VCbUhUVVoxSXJleW5tSG10enRFcjFlbVZMRHRZS0pwc2hYU2JBYnhZYXBFRWxn?oc=5","date":"2026-02-12","type":"pipeline","source":"Yahoo Finance","summary":"BCL-2 Inhibitors Market Poised for Robust Growth During the Forecast Period (2025-2034) as Oncology Pipelines Expand | DelveInsight - Yahoo Finance","headline":"BCL-2 Inhibitors Market Poised for Robust Growth During the Forecast Period (2025-2034) as Oncology Pipelines Expand | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1MN0VhQTdaM0V3bTlFS2ZVcVlYeWZIaUVNOHNZeWM3eEFxMUlWTHdWMU5ZakFZSTlnbFFENkZUNGRRTUMzNlM4bDZkd2s0T19OVkRYZUpsdWxEYkNmMEF3NjJB?oc=5","date":"2026-02-11","type":"pipeline","source":"Labiotech.eu","summary":"Eight biotech companies spearheading the antibody drug conjugate new wave - Labiotech.eu","headline":"Eight biotech companies spearheading the antibody drug conjugate new wave","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPZDVmUXN1RzJseUwyQjZUc0dfc1VRS3Y2WXR4U2x6aVRacF9DRXlFRF9USlRiY1htcENYVDY2SUFLc3BYb0dWRUtNSlZQd1JDVUdIcy1wLVI0cklXcGhvSFFYaUlKY3VYenFkVXhuZndKcjY0VjQ5ZEVxU1JtWmVGUEpjOGxoWE5rNDMyNHh4UFo?oc=5","date":"2026-01-20","type":"pipeline","source":"Buchanan Ingersoll & Rooney","summary":"New Wave of ERISA Class Action Lawsuits Name Brokers as Defendants - Buchanan Ingersoll & Rooney","headline":"New Wave of ERISA Class Action Lawsuits Name Brokers as Defendants - Buchanan Ingersoll & Rooney","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQSi1QaWJVVWJyR0U1akgxamhjYzAzZFVoWERmb0xWM2dCUjVvV29JamF4TEh6bUZ6dVdzb0VOQ3pGbDN4MjRGcGlPRUlaNWRrcXNFN0pjR201R01qcmJ1SGRqeGZDVXFiY2c0MmgzWnIxQ3pYNkMyUHNkQml5eXVtT1gxTVk1WmVKTFNFYTBvNDE4dVAxd1ZjaE45TTlzWmY0VXlTMl9ocFVHR2pPRGNXN3QtWWs?oc=5","date":"2026-01-19","type":"pipeline","source":"BioSpace","summary":"4 Next-Gen Candidates That Could Form the Future of Alzheimer’s Treatment - BioSpace","headline":"4 Next-Gen Candidates That Could Form the Future of Alzheimer’s Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNWlZEaFFUODZvSmhKWHA3aVhDWlljdVJPdXR2ZDBkRGZVck1NcWNjMVFFOEk2NkVoaDV6ZlNpdFlSYnBnVlIwVktuZDN6bG5ZMUJzRDJnRzUzNUdoQXNkUkZhUk5QRGZHSTQzT0dnRzlNNkYydVlvYmJZb2lHejROQWRZcWVSdldJOHdTazFINHlOckxPWUZkOWpvVXY5YVhUQjJHSUlhNnlQaXRCNXE0VERWaDRraWp5X0xVRkF3Ty1CdnlUUXlvTkFpUktEMFFNZXhoNTU3MEdqcWNyTENSZmNGVUFuS3U5enA0VQ?oc=5","date":"2025-12-31","type":"pipeline","source":"Stocktwits","summary":"Pfizer Leads New Wave Of 2026 US Drug Price Hikes Despite Trump’s Drug Cost Crackdown: Report - Stocktwits","headline":"Pfizer Leads New Wave Of 2026 US Drug Price Hikes Despite Trump’s Drug Cost Crackdown: Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1UN1pxem1oVVkyZ0FhSnA1S2VzdGtrWmY2MGNwZUxvWmR4YzU0Nmw2VDVEeUZnelBkcjk2UG9PU1B4YzBDUnhVQ3pWU2x3UmpMcHNaWk9GZzVndThZU1FCbVVjNjdnTTVmMHhpZml3?oc=5","date":"2025-11-17","type":"pipeline","source":"FOODStuff SA","summary":"A new wave of weight-loss meds - FOODStuff SA","headline":"A new wave of weight-loss meds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE8wTFljeERQcGxZcGJCQmFCNTBFUHQtUGFidU5YaS1uNDQtOWFQYWlFYVdyOWU3amx6ZzZPRkZRTkpFN2hJYl9LZllzaWxrS2lOUlRNV2VOYThyQmN5?oc=5","date":"2025-10-20","type":"pipeline","source":"EurekAlert!","summary":"Targeted immunotherapy combination offers hope to older adults with leukemia - EurekAlert!","headline":"Targeted immunotherapy combination offers hope to older adults with leukemia - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQT2lMaklJbk9FUk5ZUHp2RjBJNlVWNW1qb29hOW5iTVJTVFJrS2JmUVJybnVVMTRYVkdWanJLekhKUGY5WFNjc0RwaHMyaHRNN1FyMHI5V1dMZm1mUWNzOXJUNUQzOXBZd3pGUk5kZ0MyR2pyT3lSREVmSmluNHZJVTEtYi0tZVE?oc=5","date":"2025-10-15","type":"pipeline","source":"Fast Company","summary":"Can pharma trust the new wave of agentic AI? - Fast Company","headline":"Can pharma trust the new wave of agentic AI?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1NMUhva2Z3anY2OEZVM1RKd3BXaWdOVUVtSjNKeVlZV3YwR2JweXlOQVRscVU4YzV6ODQ1Si1GYnNVRFR6SUNiS1l3VGNVdkxJWl90ZDFmZmJZLVNoSE1HdGdLNk9UWC1YZm5XZ2pkQTE2cFNCZ2NaRmxQLVo?oc=5","date":"2025-06-25","type":"pipeline","source":"Pharma Voice","summary":"After myriad failures, a new wave of ALS drugs approaches - Pharma Voice","headline":"After myriad failures, a new wave of ALS drugs approaches","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOX0FoOWNzLXNDM0hteFdQUnluOExDZzZPWVNCSGZDSkNKdGE4RzhfalJxdjFyLVdibENlcWNneXdaeHdrU3hDTFJzZU0yemFDWkV2SGhoZVl3T0I3bmV4YUh5YnN3M29YRjhMZk52ZV80azJ0OXhGbnBZU0VfRzhHX25MdXo0Z05Gc0ZiUlRYbTdua3U4XzkwRGtPNFRiYkNja1BnUXdJRTMxY3FQ?oc=5","date":"2025-01-06","type":"pipeline","source":"Contract Pharma","summary":"Halia Therapeutics Updates Leadership & Clinical Operations Team - Contract Pharma","headline":"Halia Therapeutics Updates Leadership & Clinical Operations Team","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxQLUdGNExlVk1Yb25WMVhZWUlQUzgteV93WGRaSHU4WWZzMDFUYURLQXV5dFdHM3JTcERzSVQ5eUlLOFRSTXFsak8xdFJ4RmpHblB6YXJWY0tXMnhrQWluUk5OTkRqWTZvWHB0UkUyMndISW9XSS1tNDhnTDVnZmVxZm1lWUVLM3VVb2Y0dzJ2ZDExNWlhNk84RERxRkJSY2RubzhfSHZPZ3JpQ1NhSWV3ODltTlc3TF9ZWlV4LXFNWV9EdFlOT1RQNnFGeVotT3l3LWhmd2Z1Y19DcmtfQzJqdDlSaFlsZWJhWmlPMVluVkIzTmRPcTQxcDZ1UkhicGVfQUFqZ3QtZHVfTEQ1RXB4UmFkVkRmeXduUU1XQzM2YU5Jb002cnNpb01B?oc=5","date":"2024-11-28","type":"trial","source":"prnewswire.com","summary":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - prnewswire.com","headline":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therape","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}